Publikationen von F. Holsboer

Ströhle, A.; Holsboer, F.: Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 36 (Suppl. 3), S. S207 - S214 (2003)

Uhr, M.; Grauer, M. T.; Holsboer, F.: Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) p-glycoprotein gene disruption. Biological Psychiatry 54 (8), S. 840 - 846 (2003)

Adena, S. M.; Ising, M. A.; Lauer, C.; Holsboer, F.; Modell, S.: The effects of RS-86 on sleep with respect to depression and HLA-type. American Journal of Medical Genetics 114 (7), S. 754 - 754 (2002)

Binder, E. B.; Lichtner, P.; Bettecken, T.; Strom, T.; Uhr, M.; Meitinger, T.; Modell, S.; Holsboer, F.: Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Medical Genetics 114 (7), S. 752 - 753 (2002)

Holsboer, F.: The impact of genomics on antidepressant drug discovery - From serendipity to hypothesis and back. American Journal of Medical Genetics 114 (7), S. 699 - 699 (2002)

Ising, M.; Adena, S.; Binder, E.; Huber, J.; Holsboer, F.; Modell, S.: Somatic complaints and somatosensory ERPs as vulnerability markers for affective disorders. American Journal of Medical Genetics 114 (7), S. 763 - 764 (2002)

Kuenzel, H. E.; Binder, E. B.; Nickel, T.; Ising, M.; Fuchs, B.; Modell, S.; Holsboer, F.: The combined dexamethasone-suppression/corticotropin-releasing-hormone(CRH) stimulation test, a possible endophenotype for major depression? American Journal of Medical Genetics 114 (7), S. 766 - 767 (2002)

Binder, E. B.; Lichtner, P.; Uhr, M.; Bettecken, T.; Strom, T. M.; Meitinger, T.; Modell, S.; Holsboer, F.: Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Human Genetics 71 (4 Suppl. Suppl. S), S. 468 - 468 (2002)

Gesing, A.; Bilang-Bleuel, A.; Droste, S. K.; Linthorst, A. C. E.; Holsboer, F.; Reul, J. M. H. M.: Psychological stress increases hippocampal mineralocorticoid receptor levels: Involvement of corticotropin-releasing hormone. Journal of Neuroscience 21, S. 4822 - 4829 (2001)

Hermann, B.; Vollmer, I.; Holsboer, F.; Rupprecht, R.: Antidepressants do not modulate estrogen receptor α-mediated gene expression. Journal of Neural Transmission 108, S. 1197 - 1202 (2001)

Holsboer, F.: Antidepressant drug discovery in the postgenomic era. World Journal of Biological Psychiatry 2, S. 165 - 177 (2001)

Holsboer, F.: CRHR1 antagonists as novel treatment strategies. CNS Spectrums 6, S. 590 - 594 (2001)

Holsboer, F.: Prospects for antidepressant drug discovery. Biological Psychology 57, S. 47 - 65 (2001)

Holsboer, F.: Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. Journal of Affective Disorders 62, S. 77 - 91 (2001)

Hundt, W.; Zimmermann, U.; Pöttig, M.; Spring, K.; Holsboer, F.: The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcoholism: Clinical and Experimental Research 25, S. 687 - 691 (2001)

Keck, M. E.; Holsboer, F.: Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 22, S. 835 - 844 (2001)

Keck, M. E.; Welt, T.; Post, A.; Müller, M. B.; Toschi, N.; Wigger, A.; Landgraf, R.; Holsboer, F.; Engelmann, M.: Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology 24, S. 337 - 349 (2001)

Keck, M. E.; Welt, T.; Wigger, A.; Renner, U.; Engelmann, M.; Holsboer, F.; Landgraf, R.: The anxiolytic effect of the CRH₁ receptor antagonist R121919 depends on innate emotionality in rats. European Journal of Neuroscience 13, S. 373 - 380 (2001)

Krieg, J.-C.; Lauer, C. J.; Schreiber, W.; Modell, S.; Holsboer, F.: Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the "Munich vulnerability study". Journal of Affective Disorders 62, S. 33 - 37 (2001)

Lucassen, P. J.; Müller, M. B.; Holsboer, F.; Bauer, J.; Holtrop, A.; Wouda, J.; Hoogendijk, W. J. G.; De Kloet, E. R.; Swaab, D. F.: Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. American Journal of Pathology 158, S. 453 - 468 (2001)